Genetic Variants of the Copy Number Polymorphic β-Defensin Locus Are Associated with Sporadic Prostate Cancer

Background/Aims: Prostate cancer represents the cancer with the highest worldwide prevalence in men. Chromosome 8p23 has shown suggestive genetic linkage to early-onset familial prostate cancer and is frequently deleted in cancer cells of the urogenital tract. Within this locus some β-defensin genes (among them DEFB4, DEFB103, DEFB104) are localized, which are arranged in a gene cluster shown to exhibit an extensive copy number variation in the population. This structural variation considerably hampers genetic studies. In a new approach considering both sequence as well as copy number variations we aimed to compare the defensin locus at 8p23 in prostate cancer patients and controls. Methods: We apply PCR/cloning-based haplotyping and high-throughput copy number determination methods which allow assessment of both individual haplotypes and gene copy numbers not accessible to conventional SNP-based genotyping. Results: We demonstrate association of four common DEFB104 haplotypes with the risk of prostate cancer in two independent patient cohorts. Moreover, we show that high copy numbers (>9) of the defensin gene cluster are significantly underrepresented in both patient samples. Conclusions: Our findings imply a role of the antibacterial defensins in prostate cancerogenesis qualifying distinct gene variants and copy numbers as potential tumor markers.

[1]  R. Redon,et al.  Copy Number Variation: New Insights in Genome Diversity References , 2006 .

[2]  A. Schaeffer,et al.  Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. , 2000, The Journal of urology.

[3]  H. Grönberg,et al.  Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22–23 , 2003, Human Genetics.

[4]  H. Grönberg,et al.  Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden) , 2006, Cancer Causes & Control.

[5]  V. Nizet,et al.  Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer , 2006, Cell.

[6]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[7]  F. Marshall,et al.  Cancer-Specific Loss of β-Defensin 1 in Renal and Prostatic Carcinomas , 2003, Laboratory Investigation.

[8]  E. Dalmasso,et al.  Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. , 2002, Science.

[9]  Anthony J Brookes,et al.  Complex SNP-related sequence variation in segmental genome duplications , 2004, Nature Genetics.

[10]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[11]  E. Eichler,et al.  Primate segmental duplications: crucibles of evolution, diversity and disease , 2006, Nature Reviews Genetics.

[12]  L. Kwak,et al.  Roles of antimicrobial peptides such as defensins in innate and adaptive immunity , 2003, Annals of the rheumatic diseases.

[13]  K. Huse,et al.  Method for preparing single-stranded DNA templates for Pyrosequencing using vector ligation and universal biotinylated primers. , 2006, Analytical biochemistry.

[14]  G. Barsh,et al.  A β-Defensin Mutation Causes Black Coat Color in Domestic Dogs , 2007, Science.

[15]  Josefina Garcia.  Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A , 2004 .

[16]  M. Lederman,et al.  Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication , 2003 .

[17]  J. Lupski.  Genome structural variation and sporadic disease traits , 2006, Nature Genetics.

[18]  E. Bleecker,et al.  Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. , 2003, American journal of human genetics.

[19]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[20]  H. Adami,et al.  Lifestyle factors and prostate cancer risk: a case-control study in Sweden. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  K. Huse,et al.  High‐resolution mapping of the 8p23.1 beta‐defensin cluster reveals strictly concordant copy number variation of all genes , 2008, Human mutation.

[22]  W. Mars,et al.  Inheritance of Unequal Numbers of the Genes Encoding the Human Neutrophil Defensins HP-1 and HP-3 (*) , 1995, The Journal of Biological Chemistry.

[23]  Jianfeng Xu,et al.  Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8p. , 2007, Cancer research.

[24]  Å. Danielsson,et al.  β‐Defensin‐3 and ‐4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis , 2004, Clinical and experimental immunology.

[25]  C. Howald,et al.  Detection of aneuploidies by paralogous sequence quantification , 2004, Journal of Medical Genetics.

[26]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[27]  Lawrence D True,et al.  Transcriptomes of human prostate cells , 2006, BMC Genomics.

[28]  Bernhard Radlwimmer,et al.  A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. , 2006, American journal of human genetics.

[29]  J. Barber,et al.  Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. , 2003, American journal of human genetics.

[30]  J. Bonfield,et al.  A new DNA sequence assembly program. , 1995, Nucleic acids research.

[31]  T. Ganz,et al.  Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. , 2005, Genomics.

[32]  J. Chudek,et al.  Microsatellite analysis reveals deletion of a large region at chromosome 8p in conventional renal cell carcinoma , 1999, International journal of cancer.

[33]  T. Ganz,et al.  Human defensin gene copy number polymorphisms: Comprehensive analysis of independent variation in α- and β-defensin regions at 8p22–p23 , 2005 .

[34]  Enrico Petretto,et al.  Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans , 2006, Nature.

[35]  F. Marshall,et al.  Beta Defensin-1, Parvalbumin, and Vimentin: A Panel of Diagnostic Immunohistochemical Markers for Renal Tumors Derived From Gene Expression Profiling Studies Using cDNA Microarrays , 2003, The American journal of surgical pathology.

[36]  J. Carpten,et al.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. , 2001, American journal of human genetics.

[37]  M. den Heijer,et al.  Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats , 2006, Nucleic acids research.

[38]  B. Rovin,et al.  The Influence of CCL 3 L 1 Gene – Containing Segmental Duplications on HIV-1 / AIDS Susceptibility , 2009 .

[39]  Chuanshu Huang,et al.  Inflammation, a Key Event in Cancer Development , 2006, Molecular Cancer Research.

[40]  M. Lederman,et al.  Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. , 2003, AIDS.

[41]  M. Newton,et al.  Identification of the prostate cancer micro-foci with chromosome 8p deletion at the tumor interface area by histopathological-FISH parallel examination. , 2001, International journal of oncology.

[42]  H. Grönberg,et al.  Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. , 2004, Cancer research.

[43]  J. Stanford,et al.  Sexual factors and the risk of prostate cancer. , 2001, American journal of epidemiology.

[44]  E. Dalmasso,et al.  Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor , 2002, Science.

[45]  F. Marshall,et al.  Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. , 2003, Laboratory investigation; a journal of technical methods and pathology.

[46]  Jianfeng Xu,et al.  Inflammation in prostate carcinogenesis , 2007, Nature Reviews Cancer.

[47]  André Reis,et al.  Psoriasis is associated with increased beta-defensin genomic copy number. , 2008, Nature genetics.

[48]  Matthias Platzer,et al.  Polymorphic segmental duplications at 8p23.1 challenge the determination of individual defensin gene repertoires and the assembly of a contiguous human reference sequence , 2004, BMC Genomics.